“Circulating fibroblast growth factor-23 is associated with increased risk for metachronous colorectal adenoma” (2011) Journal of Carcinogenesis, 10(1). Available at: https://carcinogenesis.com/index.php/JOC/article/view/146 (Accessed: 8 December 2025).